- People living with MS in Colorado are turning to cannabis as alternative therapy
- Thorsten Rudroff from Colorado State University says his lab can't conduct tests because of federal regulations
- But doctors can't recommend a strain because of lack scientific evidence
- Colorado has been the epicenter of marijuana legalization in the US
An estimated 400,000 Americans are
currently living with multiple sclerosis, an autoimmune disease where
the body's immune cells attack a fatty substance called myelin in the
nerves.
Common symptoms are gait and balance disorders, cognitive dysfunction, fatigue, pain and muscle spasticity.
Colorado
has the highest proportion of people living with MS in the United
States. It is estimated that one in 550 people living in the state has
MS, compared to one in 750 nationally.
The reason for this is unknown, but could be related to several factors, such as vitamin D deficiency or environment.
Currently
available therapies do not sufficiently relieve MS symptoms. As a
result many people with the condition are trying alternative therapies,
like cannabis.
A woman with MS leaves a licensed
medical cannabis dispensary in Illinois. Many people living with MS in
Colorado have turned to alternative therapies like cannabis. Colorado
has the highest proportion of people living with MS in the US
Based
on several studies, the American Association of Neurology states that
there is strong evidence that cannabis is effective for treatment of
pain and spasticity.
Although there are
many anecdotal reports indicating cannabis' beneficial effects for
treatment of MS symptoms such as fatigue, muscle weakness, anxiety and
sleep deprivation, they have not been scientifically verified.
This
is because clinical trials – where patients are given cannabis – are
difficult to do because of how the substance is regulated at the federal
level.
To learn more, my Integrative
Neurophysiology Laboratory at Colorado State University is studying
people with MS in the state who are already using medical cannabis as a
treatment to investigate what MS symptoms the drug can effectively
treat.
No comments:
Post a Comment